factual

MDMA therapy furthest along to FDA approval for PTSD

MDMA-assisted therapy is the furthest along toward federal approval; MAPS sponsored two positive phase 3 trials for PTSD (the second published in Nature Medicine), satisfying the FDA's requirement for two positive trials, with approval forecast for the following year, though the on-label indication would initially be PTSD only (with off-label prescribing possible).

factualpending

Speaker

Robin Carhart-Harris

Evidence Quote

“mdma therapy is the furthest along in terms of being federally approved as a prescriptible medicine”

Source

337 - The Future Of Psychedelic Medicine— Making Sense with Sam Harris
Created: 6/14/2026, 2:20:20 AM

Your notes

Loading notes...